GR3017737T3 - Low dose dry pharmaceutical preparations. - Google Patents
Low dose dry pharmaceutical preparations.Info
- Publication number
- GR3017737T3 GR3017737T3 GR950402836T GR950402836T GR3017737T3 GR 3017737 T3 GR3017737 T3 GR 3017737T3 GR 950402836 T GR950402836 T GR 950402836T GR 950402836 T GR950402836 T GR 950402836T GR 3017737 T3 GR3017737 T3 GR 3017737T3
- Authority
- GR
- Greece
- Prior art keywords
- disclosed
- weight
- agent
- pharmaceutical preparations
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91200524 | 1991-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3017737T3 true GR3017737T3 (en) | 1996-01-31 |
Family
ID=8207548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR950402836T GR3017737T3 (en) | 1991-03-12 | 1995-10-16 | Low dose dry pharmaceutical preparations. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5382434A (el) |
EP (1) | EP0503521B2 (el) |
JP (1) | JP3474210B2 (el) |
KR (1) | KR100198017B1 (el) |
CN (1) | CN1039086C (el) |
AT (1) | ATE125155T1 (el) |
AU (1) | AU651869B2 (el) |
CA (1) | CA2062428C (el) |
DE (1) | DE69203488T3 (el) |
DK (1) | DK0503521T4 (el) |
ES (1) | ES2077897T5 (el) |
FI (1) | FI100770B (el) |
GR (1) | GR3017737T3 (el) |
HK (1) | HK1002018A1 (el) |
IE (1) | IE67345B1 (el) |
NO (1) | NO305055B1 (el) |
NZ (1) | NZ241915A (el) |
ZA (1) | ZA921659B (el) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA924617B (en) | 1991-03-25 | 1994-05-27 | Boart International S A Pty Lt | A percussion drill bit |
ZA939565B (en) * | 1993-12-21 | 1994-08-11 | Applied Analytical Ind Inc | Method for preparing low dose pharmaceutical products. |
US5928668A (en) * | 1993-12-21 | 1999-07-27 | Applied Analytical Industries, Inc. | Method for dry blend compression of medicaments |
ZA939566B (en) * | 1993-12-21 | 1994-08-11 | Applied Analytical Ind Inc | Method for dry blend compression od medicaments. |
US5976570A (en) * | 1993-12-21 | 1999-11-02 | Applied Analytical Industries, Inc. | Method for preparing low dose pharmaceutical products |
ZA949929B (en) * | 1993-12-23 | 1995-08-23 | Akzo Nobel Nv | Sugar-coated pharmaceutical dosage unit. |
US6077533A (en) * | 1994-05-25 | 2000-06-20 | Purdue Pharma L.P. | Powder-layered oral dosage forms |
DK0782449T3 (da) * | 1994-09-22 | 2003-08-04 | Akzo Nobel Nv | Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering |
CA2159419C (en) * | 1994-10-17 | 2006-07-04 | Pieter De Haan | Solid pharmaceutical composition comprising an excipient capable of binding water |
WO1997026798A1 (en) * | 1995-01-25 | 1997-07-31 | Wm. Wrigley Jr. Company | Improved rolling compound and methods of manufacturing chewing gum using same |
DK0833642T3 (da) * | 1995-06-22 | 2002-06-10 | Akzo Nobel Nv | Komprimerede tør-granulerede desogestreltabletter |
DE19652196A1 (de) | 1996-12-16 | 1998-06-18 | Jenapharm Gmbh | Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen |
WO2000050041A1 (en) * | 1999-02-24 | 2000-08-31 | Akzo Nobel N.V. | Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose |
KR20010006835A (ko) * | 1999-03-25 | 2001-01-26 | 김선진 | 경구용 속붕해정 |
DE19917347A1 (de) * | 1999-04-16 | 2000-11-09 | Gsf Forschungszentrum Umwelt | Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe |
ITMI991582A1 (it) * | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
FR2796840B1 (fr) * | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | Comprimes faiblement doses et procede de preparation |
US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
FR2801218B1 (fr) * | 1999-11-23 | 2001-12-28 | Hoechst Marion Roussel Inc | Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant |
CA2395129C (en) * | 1999-12-20 | 2008-12-16 | Nicholas J. Kerkhof | Process for producing nanometer particles by fluid bed spray-drying |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
DE60130657T2 (de) * | 2000-07-20 | 2008-07-03 | Campina Nederland Holding B.V. | Methode zur herstellung eines kristallinen tablettierungshilfstoffes, der so erhaltene hilfsstoff und seine verwendung |
EE05358B1 (et) * | 2000-12-14 | 2010-12-15 | Ortho-Mcneil Pharmaceutical, Inc. | Steroidhormoonprodukt ja selle valmistamismeetod |
WO2002069934A1 (fr) * | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co., Ltd. | Préparations se délitant rapidement dans la bouche |
WO2002070013A1 (fr) * | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co., Ltd. | Utilisation d'une poudre sechee par atomisation contenant un alcool de sucre |
AP2003002900A0 (en) * | 2001-05-01 | 2003-12-31 | Pfizer Prod Inc | Method for manufacturing a low dose pharmaceutical composition |
US7118765B2 (en) | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
US6962908B2 (en) * | 2001-12-21 | 2005-11-08 | Warner Chilcott Company Inc. | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
ATE461681T1 (de) | 2003-04-29 | 2010-04-15 | Gen Hospital Corp | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln |
US7444197B2 (en) | 2004-05-06 | 2008-10-28 | Smp Logic Systems Llc | Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes |
US7799273B2 (en) | 2004-05-06 | 2010-09-21 | Smp Logic Systems Llc | Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes |
TWI356036B (en) * | 2004-06-09 | 2012-01-11 | Smithkline Beecham Corp | Apparatus and method for pharmaceutical production |
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
WO2009017456A1 (en) * | 2007-08-01 | 2009-02-05 | Hjerten Stellan | Pharmaceutical composition suitable for adsorption to the cell surface of pathogenic microbes |
JP2012505253A (ja) * | 2008-10-10 | 2012-03-01 | テバ ウィメンズ ヘルス インコーポレイテッド | 低用量酢酸シプロテロンを用いる、去勢された前立腺癌患者における血管運動症状の治療方法 |
JP5806124B2 (ja) | 2009-03-09 | 2015-11-10 | エスピーアイ ファーマ,インコーポレイテッド | 高度に圧密可能かつ耐久性のある直接圧縮賦形剤および賦形剤系 |
HUP0900698A2 (en) | 2009-11-06 | 2011-06-28 | Richter Gedeon Nyrt | Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation |
EP2354150A1 (en) * | 2010-02-09 | 2011-08-10 | Laboratoire Theramex | Process for the preparation of gestodene |
WO2012120365A1 (en) | 2011-03-07 | 2012-09-13 | Aurobindo Pharma Limited | Stable pharmaceutical composition comprising ethinyl estradiol |
CN102416003A (zh) * | 2011-12-08 | 2012-04-18 | 南京优科生物医药有限公司 | 一种制备恩替卡韦片剂的方法 |
DK2964199T3 (da) * | 2013-03-04 | 2020-06-15 | Besins Healthcare Lu Sarl | Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3626063A (en) * | 1959-08-11 | 1971-12-07 | Upjohn Co | Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof |
US3344030A (en) * | 1964-06-15 | 1967-09-26 | American Home Prod | Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables |
US3423507A (en) * | 1966-02-25 | 1969-01-21 | Schering Corp | Method of treating benign prostratic hypertrophy |
US3568828A (en) * | 1967-03-01 | 1971-03-09 | Squibb & Sons Inc | Modified sequential oral contraceptive |
US3671633A (en) * | 1971-05-10 | 1972-06-20 | American Cyanamid Co | Process for tabletting acetazolamide |
US3802914A (en) * | 1972-04-10 | 1974-04-09 | Kraftco Corp | Method of treating lactose |
SE378109B (el) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
DE2365103C3 (de) * | 1973-12-21 | 1980-08-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | V erwendung von Hormonen zur Kontrazeption |
DE2524902C2 (de) * | 1975-06-02 | 1984-10-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | Vorrichtung zur Inhalation von Arzneimitteln |
US4143136A (en) * | 1976-11-20 | 1979-03-06 | Akzona Incorporated | Method of contraception |
DE2716323C2 (de) * | 1977-04-07 | 1986-03-13 | Schering AG, 1000 Berlin und 4709 Bergkamen | Vorrichtung zur Inhalation von Arzneimitteln |
NL8001593A (nl) * | 1980-03-18 | 1981-10-16 | Akzo Nv | Meerfasisch combinatiepreparaat voor orale anticonceptie. |
US4628051A (en) * | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
DE3505433A1 (de) * | 1985-02-16 | 1986-08-21 | Basf Ag, 6700 Ludwigshafen | Direkttablettierhilfsmittel |
DE3506276C1 (de) * | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direkttablettiermittel |
US4916163A (en) * | 1985-06-04 | 1990-04-10 | The Upjohn Company | Spray-dried lactose formulation of micronized glyburide |
-
1992
- 1992-02-27 IE IE920634A patent/IE67345B1/en not_active IP Right Cessation
- 1992-03-05 CA CA002062428A patent/CA2062428C/en not_active Expired - Lifetime
- 1992-03-05 ZA ZA921659A patent/ZA921659B/xx unknown
- 1992-03-06 AU AU12119/92A patent/AU651869B2/en not_active Expired
- 1992-03-09 AT AT92103963T patent/ATE125155T1/de active
- 1992-03-09 ES ES92103963T patent/ES2077897T5/es not_active Expired - Lifetime
- 1992-03-09 FI FI921023A patent/FI100770B/fi not_active IP Right Cessation
- 1992-03-09 EP EP92103963A patent/EP0503521B2/en not_active Expired - Lifetime
- 1992-03-09 DK DK92103963T patent/DK0503521T4/da active
- 1992-03-09 DE DE69203488T patent/DE69203488T3/de not_active Expired - Lifetime
- 1992-03-10 NZ NZ241915A patent/NZ241915A/en not_active IP Right Cessation
- 1992-03-11 NO NO920958A patent/NO305055B1/no not_active IP Right Cessation
- 1992-03-11 CN CN92101566A patent/CN1039086C/zh not_active Expired - Lifetime
- 1992-03-11 KR KR1019920003956A patent/KR100198017B1/ko not_active IP Right Cessation
- 1992-03-12 JP JP05393692A patent/JP3474210B2/ja not_active Expired - Lifetime
-
1994
- 1994-03-22 US US08/216,236 patent/US5382434A/en not_active Expired - Lifetime
-
1995
- 1995-10-16 GR GR950402836T patent/GR3017737T3/el unknown
-
1998
- 1998-02-11 HK HK98101029A patent/HK1002018A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO920958D0 (no) | 1992-03-11 |
DE69203488D1 (de) | 1995-08-24 |
FI921023A0 (fi) | 1992-03-09 |
HK1002018A1 (en) | 1998-07-24 |
IE920634A1 (en) | 1992-09-23 |
JPH0578251A (ja) | 1993-03-30 |
EP0503521A1 (en) | 1992-09-16 |
NZ241915A (en) | 1994-04-27 |
AU651869B2 (en) | 1994-08-04 |
IE67345B1 (en) | 1996-03-20 |
CN1039086C (zh) | 1998-07-15 |
EP0503521B1 (en) | 1995-07-19 |
NO305055B1 (no) | 1999-03-29 |
KR100198017B1 (ko) | 1999-06-15 |
ZA921659B (en) | 1992-11-25 |
FI921023A (fi) | 1992-09-13 |
DE69203488T2 (de) | 1996-01-11 |
CA2062428C (en) | 2002-07-30 |
ATE125155T1 (de) | 1995-08-15 |
FI100770B (fi) | 1998-02-27 |
US5382434A (en) | 1995-01-17 |
DE69203488T3 (de) | 2006-07-06 |
CN1064810A (zh) | 1992-09-30 |
KR920017656A (ko) | 1992-10-21 |
ES2077897T5 (es) | 2006-06-16 |
ES2077897T3 (es) | 1995-12-01 |
DK0503521T3 (da) | 1995-11-27 |
EP0503521B2 (en) | 2005-11-09 |
JP3474210B2 (ja) | 2003-12-08 |
NO920958L (no) | 1992-09-14 |
DK0503521T4 (da) | 2005-12-05 |
CA2062428A1 (en) | 1992-09-13 |
AU1211992A (en) | 1992-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3017737T3 (en) | Low dose dry pharmaceutical preparations. | |
IE891414L (en) | Pharmaceutical compositions | |
CA2152795A1 (en) | Readily available konjac glucomannan sustained release excipient | |
RU93036959A (ru) | Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства | |
KR920006909B1 (ko) | 니트렌디핀을 함유하는 고상 약제의 제조 방법 | |
IL108071A0 (en) | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them | |
EP0391374A3 (en) | Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products | |
GB1427881A (en) | Mixtures containing nitroglycerin and polyvinyl-pyrrolidone | |
US4206214A (en) | Antithrombotic pharmaceutical compositions containing dipyridamole and sulfinpyrazone | |
HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
ZA939565B (en) | Method for preparing low dose pharmaceutical products. | |
EP0414688B1 (en) | Process for regulating the absorption rate of drugs and a pharmaceutical formulation | |
DE69209916T2 (de) | Oral anzuwendende Arzneimittel Dapiprazol enthaltend | |
CA2201040A1 (en) | Solid pharmaceutical preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide | |
DK0483320T3 (da) | Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf | |
MX9800809A (es) | Procedimiento para preparar formas de dosis solidas de dosis muy bajas del farmaco. | |
Fateeva | Pharmacokinetics of amphoglucamine in an experiment | |
WO2001010415B1 (en) | A binder for pharmaceutical compositions | |
NO176948C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat i enhetsdoseform omfattende finmalt colestipol-hydroklorid | |
GB1255805A (en) | Improvements in delayed release pharmaceutical preparations and stabilisation of vitamins | |
EP0347531A3 (en) | Use of 1,3-dithiole-2-thione-derivatives in therapy of hepatic diseases | |
JPS5462327A (en) | Remedy for dna virus infectious disease | |
JPS57112327A (en) | Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid | |
CA2176461A1 (en) | Method for preparing low dose pharmaceutical products | |
JPS57112329A (en) | Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid |